SThree (LON:STEM – Free Report) had its price objective decreased by Berenberg Bank from GBX 520 ($6.56) to GBX 390 ($4.92) in a research note issued to investors on Thursday, MarketBeat Ratings reports. Berenberg Bank currently has a buy rating on the stock.
SThree Stock Up 1.9 %
STEM stock opened at GBX 270 ($3.41) on Thursday. The company has a market cap of £358.83 million, a price-to-earnings ratio of 642.86, a P/E/G ratio of 0.75 and a beta of 0.98. SThree has a twelve month low of GBX 221.50 ($2.80) and a twelve month high of GBX 457.50 ($5.77). The business has a 50 day moving average price of GBX 355.10 and a two-hundred day moving average price of GBX 391.53. The company has a quick ratio of 1.69, a current ratio of 1.89 and a debt-to-equity ratio of 11.91.
Insider Activity at SThree
In other news, insider Elaine ODonnell acquired 5,500 shares of the stock in a transaction on Thursday, November 14th. The shares were purchased at an average price of GBX 344 ($4.34) per share, for a total transaction of £18,920 ($23,879.84). Also, insider Timo Lehne purchased 85,028 shares of the firm’s stock in a transaction that occurred on Wednesday, September 25th. The stock was acquired at an average price of GBX 375 ($4.73) per share, for a total transaction of £318,855 ($402,442.26). In the last ninety days, insiders bought 90,633 shares of company stock worth $33,813,420. Insiders own 6.23% of the company’s stock.
SThree Company Profile
SThree plc provides specialist recruitment services in the sciences, technology, engineering, and mathematics markets in the United Kingdom, Austria, Germany, Switzerland, Netherlands, Spain, Belgium, France, the United States, Dubai, Japan. The company offers recruitment services for permanent and contract roles, as well as support services.
Featured Articles
- Five stocks we like better than SThree
- Most Volatile Stocks, What Investors Need to Know
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- Options Trading – Understanding Strike Price
- Texas Instruments: The Old-School Tech Titan Still Delivering
- What is a Low P/E Ratio and What Does it Tell Investors?
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for SThree Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SThree and related companies with MarketBeat.com's FREE daily email newsletter.